BioBond Continues to Grow Its IP Portfolio to Commercialize Sustainable Adhesives and Coating Solutions LAFAYETTE, INDIANA / ACCESS Newswire / February 11, 2025 / BioBond Adhesives, Inc. ("BioBond" or ...
BioBond Continues to Grow Its IP Portfolio to Commercialize Sustainable Adhesives and Coating Solutions LAFAYETTE, INDIANA / ...
WEST LAFAYETTE − Purdue basketball's defense got it through a tough road trip to the Pacific Northwest. The Boilermakers saw their seven-game winning streak end because the offense couldn't ...
McKinsey & Company Inc., a management consulting firm, recently agreed to pay $650 million to resolve a civil and criminal investigation into consulting work performed by the firm with opioids ...
Officials in states and local governments claimed that the opioid crisis was exacerbated by Purdue Pharma’s OxyContin and ...
Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion to settle lawsuits over the toll of the powerful prescription ...
20d
Hosted on MSNPurdue Pharma Agrees To $7 Billion Settlement Over OxyContin's Role In Opioid CrisisBankrupt Purdue Pharma LP and its owners have agreed to over $7 billion settlement to resolve lawsuits over OxyContin's role in the opioid epidemic. The deal follows the U.S. Supreme Court’s rejection ...
A federal judge extended a pause protecting the Sackler family, owners of Purdue Pharma LP, from opioid lawsuits to give the OxyContin maker, states and victims representatives time to finalize a new ...
The Sackler dynasty, owners of Purdue Pharma and makers of powerful prescription painkiller OxyContin, has agreed to pay up to $7.4 billion of their own money to settle claims over its role in ...
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results